[Experiences with 5-phenyl-2-imino-4-oxazolidinone in mental patients].
D000697:Central Nervous System Stimulants / Q000628:therapy*; D004565:Electroconvulsive Therapy; D001523:Mental Disorders / Q000628:therapy*; D028642:Persons with Psychiatric Disorders; D023303:Oxazolidinones; D011612:Psychosurgery; D011613:Psychotherapy
D000697:Central Nervous System Stimulants; D023303:Oxazolidinones
ANALEPTICS/therapy; MENTAL DISORDERS/therapy